Literature DB >> 26467260

Effect of resveratrol on metabolic and cardiovascular function in male and female adult offspring exposed to prenatal hypoxia and a high-fat diet.

Amin Shah1,2, Laura M Reyes1,2,3, Jude S Morton1,2, David Fung1, Jillian Schneider1, Sandra T Davidge1,2,3.   

Abstract

Prenatal hypoxia, a common outcome of pregnancy complications, predisposes offspring to the development of metabolic and cardiovascular disorders in later life. We have previously observed that resveratrol improved cardiovascular and metabolic health in adult male rat offspring exposed to prenatal hypoxia and a postnatal high-fat (HF) diet; however, the effects of resveratrol in female rat offspring are not known. Our aim was to identify the mechanism(s) by which resveratrol may prevent metabolic and cardiac dysfunction in both male and female rat offspring exposed to prenatal hypoxia and a postnatal HF diet. Offspring that experienced normoxia or hypoxia in utero were fed a HF diet or a HF diet supplemented with resveratrol for 9 weeks following weaning. Body composition, metabolic function, in vivo cardiac function and ex vivo cardiac susceptibility to ischaemia-reperfusion (I/R) injury were assessed at 12 weeks of age. Prenatal hypoxia impaired metabolic function in male, but not female, rat offspring fed a HF diet and this was improved by resveratrol supplementation. Prenatal hypoxia also led to reduced recovery from cardiac I/R injury in male, and to a lesser extent in female, rat offspring fed a HF diet. Indices of cardiac oxidative stress after I/R were enhanced in both male and female rat offspring exposed to prenatal hypoxia. Resveratrol improved cardiac recovery from I/R injury and attenuated superoxide levels in both male and female rat offspring. In conclusion, prenatal hypoxia impaired metabolic and cardiac function in a sex-specific manner. Resveratrol supplementation may improve metabolic and cardiovascular health in adult male and female rat offspring exposed to prenatal hypoxia.
© 2015 The Authors. The Journal of Physiology © 2015 The Physiological Society.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26467260      PMCID: PMC4771791          DOI: 10.1113/JP271133

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  57 in total

1.  Long-term effects of intrauterine growth restriction on cardiac metabolism and susceptibility to ischaemia/reperfusion.

Authors:  Christian F Rueda-Clausen; Jude S Morton; Gary D Lopaschuk; Sandra T Davidge
Journal:  Cardiovasc Res       Date:  2010-11-19       Impact factor: 10.787

2.  Effects of hypoxia-induced intrauterine growth restriction on cardiopulmonary structure and function during adulthood.

Authors:  Christian F Rueda-Clausen; Jude S Morton; Sandra T Davidge
Journal:  Cardiovasc Res       Date:  2008-12-16       Impact factor: 10.787

3.  Hypoxia-derived oxidative stress mediates epigenetic repression of PKCε gene in foetal rat hearts.

Authors:  Andrew J Patterson; Daliao Xiao; Fuxia Xiong; Brandon Dixon; Lubo Zhang
Journal:  Cardiovasc Res       Date:  2011-12-02       Impact factor: 10.787

Review 4.  Oxidative stress and antioxidants in hypertension-a current review.

Authors:  Nakshi Sinha; Pradeep Kumar Dabla
Journal:  Curr Hypertens Rev       Date:  2015

5.  Resveratrol has no effect on lipoprotein profile and does not prevent peroxidation of serum lipids in normal rats.

Authors:  J F Turrens; J Lariccia; M G Nair
Journal:  Free Radic Res       Date:  1997-12

6.  Effect of intrauterine growth restriction on blood pressure, glucose tolerance and sympathetic nervous system activity in the rat at 3-4 months of age.

Authors:  T Jansson; G W Lambert
Journal:  J Hypertens       Date:  1999-09       Impact factor: 4.844

7.  Cardioprotection with resveratrol pretreatment: improved beneficial effects over standard treatment in rat hearts after global ischemia.

Authors:  S Dernek; M Ikizler; N Erkasap; B Ergun; T Koken; K Yilmaz; B Sevin; Z Kaygisiz; T Kural
Journal:  Scand Cardiovasc J       Date:  2004-08       Impact factor: 1.589

8.  Assessment of fetal compromise by Doppler ultrasound investigation of the fetal circulation. Arterial, intracardiac, and venous blood flow velocity studies.

Authors:  K Hecher; S Campbell; P Doyle; K Harrington; K Nicolaides
Journal:  Circulation       Date:  1995-01-01       Impact factor: 29.690

9.  Low birth weight is associated with components of the metabolic syndrome.

Authors:  Xinhua Xiao; Zhen-Xin Zhang; Wen-Hui Li; Kai Feng; Qi Sun; Harvey Jay Cohen; Tao Xu; Heng Wang; Ai-Min Liu; Xiao-Ming Gong; Ying Shen; Zeng Yi
Journal:  Metabolism       Date:  2010-01-04       Impact factor: 8.694

10.  Resveratrol attenuates obesity-associated peripheral and central inflammation and improves memory deficit in mice fed a high-fat diet.

Authors:  Byeong Tak Jeon; Eun Ae Jeong; Hyun Joo Shin; Younghyurk Lee; Dong Hoon Lee; Hyun Joon Kim; Sang Soo Kang; Gyeong Jae Cho; Wan Sung Choi; Gu Seob Roh
Journal:  Diabetes       Date:  2012-02-23       Impact factor: 9.461

View more
  21 in total

1.  Foetal hypoxia impacts methylome and transcriptome in developmental programming of heart disease.

Authors:  Lei Huang; Xin Chen; Chiranjib Dasgupta; Wanqiu Chen; Rui Song; Charles Wang; Lubo Zhang
Journal:  Cardiovasc Res       Date:  2019-07-01       Impact factor: 10.787

2.  Increased susceptibility to cardiovascular disease in offspring born from dams of advanced maternal age.

Authors:  Christy-Lynn M Cooke; Amin Shah; Raven D Kirschenman; Anita L Quon; Jude S Morton; Alison S Care; Sandra T Davidge
Journal:  J Physiol       Date:  2018-06-21       Impact factor: 5.182

3.  Maternal resveratrol supplementation ameliorates bisphenol A-induced atherosclerotic lesions formation in adult offspring ApoE-/- mice.

Authors:  Srinivasa Rao Sirasanagandla; Isehaq Al-Huseini; Mohamed Al Mushaiqri; Nadia Al-Abri; Fatma Al-Ghafri
Journal:  3 Biotech       Date:  2022-01-04       Impact factor: 2.406

4.  Resveratrol partially prevents oxidative stress and metabolic dysfunction in pregnant rats fed a low protein diet and their offspring.

Authors:  Claudia C Vega; Luis A Reyes-Castro; Guadalupe L Rodríguez-González; Claudia J Bautista; Magaly Vázquez-Martínez; Fernando Larrea; Germán A Chamorro-Cevallos; Peter W Nathanielsz; Elena Zambrano
Journal:  J Physiol       Date:  2016-01-18       Impact factor: 5.182

Review 5.  Gestational Hypoxia and Developmental Plasticity.

Authors:  Charles A Ducsay; Ravi Goyal; William J Pearce; Sean Wilson; Xiang-Qun Hu; Lubo Zhang
Journal:  Physiol Rev       Date:  2018-07-01       Impact factor: 37.312

6.  Hypoxia, fetal and neonatal physiology: 100 years on from Sir Joseph Barcroft.

Authors:  D A Giussani; L Bennet; A N Sferruzzi-Perri; O R Vaughan; A L Fowden
Journal:  J Physiol       Date:  2016-03-01       Impact factor: 5.182

7.  Cardioprotection stimulated by resveratrol and grape products prevents lethal cardiac arrhythmias in an animal model of ischemia and reperfusion.

Authors:  Francisco Sandro Menezes-Rodrigues; Paolo Ruggero Errante; Erisvaldo Amarante Araújo; Mariana Pontes Pacheco Fernandes; Michele Mendes da Silva; Marcelo Pires-Oliveira; Carla Alessandra Scorza; Fúlvio Alexandre Scorza; Murched Omar Taha; Afonso Caricati-Neto
Journal:  Acta Cir Bras       Date:  2021-05-07       Impact factor: 1.388

8.  Postnatal resveratrol supplementation improves cardiovascular function in male and female intrauterine growth restricted offspring.

Authors:  Amin Shah; Anita Quon; Jude S Morton; Sandra T Davidge
Journal:  Physiol Rep       Date:  2017-01

Review 9.  Interplay between Oxidative Stress and Nutrient Sensing Signaling in the Developmental Origins of Cardiovascular Disease.

Authors:  You-Lin Tain; Chien-Ning Hsu
Journal:  Int J Mol Sci       Date:  2017-04-15       Impact factor: 5.923

10.  Hypoxia reduces placental mTOR activation in a hypoxia-induced model of intrauterine growth restriction (IUGR).

Authors:  Rebecca Kimball; Montana Wayment; Daniel Merrill; Tyler Wahlquist; Paul R Reynolds; Juan A Arroyo
Journal:  Physiol Rep       Date:  2015-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.